BILLY RAINES — Lobbyist Profile | Poliscope

BILLY RAINES

Reported covered position: Office of Congressman John Boccieri 2010-2011; Office of Congresswoman Betty Sutton 2011-2012

Filings

Clients

Firms

Years active

2024–2026

Associated filing income

—

How to read the money

Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.

Clients represented

Client	Filings	Years
DEXCOM INC	11	2024–2026

Lobbying firms

Firm	Filings	Years
DEXCOM INC	11	2024–2026

Bills explicitly cited in this lobbyist’s assigned issues (19)

No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.

H.R. 1539

Medical Device Electronic Labeling Act

Client: DEXCOM, INC. · Firm: DEXCOM, INC.

Open original LDA filing ↗

Cited source text

CGM Coverage policy Issues related to sterilization of medical devices Issues related to medical device electronic labeling H.R.1539, Medical Device Electronic Labeling Act Issues related to artificial intelligence and other machine learning advances in healthcare Issues related to advances in diabetes technology Issues related to CY 2026 rulemaking

H.R. 1539

Medical Device Electronic Labeling Act

Client: DEXCOM, INC. · Firm: DEXCOM, INC.

Open original LDA filing ↗

Cited source text

Original LDA source filings (11)

Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.

DEXCOM, INC. via DEXCOM, INC.

2026 · third_quarter · Q3

Firm income: —Client expense: $320,000Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

TRD

Trade (domestic/foreign)

Issues related to global supply chains Issues related to the Administration's Executive Orders

HCR

Health Issues

CGM Coverage policy Issues related to sterilization of medical devices Issues related to medical device electronic labeling H.R.1539, Medical Device Electronic Labeling Act Issues related to artificial intelligence and other machine learning advances in healthcare Issues related to advances in diabetes technology Issues related to CY 2026 rulemaking

Source: Senate LDA

Show 15 more cited filings

H.R. 1539

Medical Device Electronic Labeling Act

Client: DEXCOM, INC. · Firm: DEXCOM, INC.

Open original LDA filing ↗

Cited source text

CGM Coverage policy Issues related to sterilization of medical devices Issues related to medical device electronic labeling H.R.1539, Medical Device Electronic Labeling Act Issues related to artificial intelligence and other machine learning advances in healthcare Issues related to advances in diabetes technology

H.R. 1539

Medical Device Electronic Labeling Act

Client: DEXCOM, INC. · Firm: DEXCOM, INC.

Open original LDA filing ↗

Cited source text

CGM Coverage policy Issues related to sterilization of medical devices Issues related to medical device electronic labeling H.R.1539, Medical Device Electronic Labeling Act Issues related to artificial intelligence and other machine learning advances in healthcare Issues related to advances in diabetes technology Issues related to CY 2026 rulemaking

H.R. 1539

Medical Device Electronic Labeling Act

Client: DEXCOM, INC. · Firm: DEXCOM, INC.

Open original LDA filing ↗

Cited source text

CGM Coverage policy Issues related to sterilization of medical devices Issues related to medical device electronic labeling H.R.1539, Medical Device Electronic Labeling Act Issues related to artificial intelligence and other machine learning advances in healthcare Issues related to advances in diabetes technology

H.R. 1328

Medical Device Nonvisual Accessibility Act of 2023

Client: DEXCOM, INC. · Firm: DEXCOM, INC.

Open original LDA filing ↗

Cited source text

CGM Coverage policy Issues related to sterilization of medical devices Issues related to medical device electronic labeling H.R.3723, Medical Device Electronic Labeling Act H.R.1328, Medical Device Nonvisual Accessibility Act Issues related to artificial intelligence and other machine learning advances in healthcare Issues related to advances in diabetes technology

H.R. 1328

Medical Device Nonvisual Accessibility Act of 2023

Client: DEXCOM, INC. · Firm: DEXCOM, INC.

Open original LDA filing ↗

Cited source text

CGM Coverage policy Issues related to sterilization of medical devices Issues related to medical device electronic labeling H.R.3723, Medical Device Electronic Labeling Act H.R.1328, Medical Device Nonvisual Accessibility Act Issues related to artificial intelligence and other machine learning advances in healthcare Issues related to advances in diabetes technology

H.R. 1328

Medical Device Nonvisual Accessibility Act of 2023

Client: DEXCOM, INC. · Firm: DEXCOM, INC.

Open original LDA filing ↗

Cited source text

CGM Coverage policy Issues related to sterilization of medical devices Issues related to medical device electronic labeling H.R.3723, Medical Device Electronic Labeling Act H.R.1328, Medical Device Nonvisual Accessibility Act Issues related to artificial intelligence and other machine learning advances in healthcare Issues related to advances in diabetes technology

H.R. 1328

Medical Device Nonvisual Accessibility Act of 2023

Client: DEXCOM, INC. · Firm: DEXCOM, INC.

Open original LDA filing ↗

Cited source text

CGM Coverage policy Issues related to the sterilization of medical devices Issues related to medical device electronic labeling H.R.3723, Medical Device Electronic Labeling Act H.R.1328, Medical Device Nonvisual Accessibility Act Issues related to artificial intelligence and other machine learning advances in healthcare Issues related to advances in diabetes technology

H.R. 1691

Ensuring Patient Access to Critical Breakthrough Products Act of 2024

Client: DEXCOM, INC. · Firm: DEXCOM, INC.

Open original LDA filing ↗

Cited source text

CGM Coverage policies Issues related to Medicare coverage and payment for breakthrough medical devices H.R.1691, Ensuring Patient Access to Critical Breakthrough Products Act

H.R. 1691

Ensuring Patient Access to Critical Breakthrough Products Act of 2024

Client: DEXCOM, INC. · Firm: DEXCOM, INC.

Open original LDA filing ↗

Cited source text

CGM Coverage policies Issues related to Medicare coverage and payment for breakthrough medical devices H.R.1691, Ensuring Patient Access to Critical Breakthrough Products Act

H.R. 1691

Ensuring Patient Access to Critical Breakthrough Products Act of 2024

Client: DEXCOM, INC. · Firm: DEXCOM, INC.

Open original LDA filing ↗

Cited source text

CGM Coverage policies Issues related to Medicare coverage and payment for breakthrough medical devices H.R.1691, Ensuring Patient Access to Critical Breakthrough Products Act

H.R. 1691

Ensuring Patient Access to Critical Breakthrough Products Act of 2024

Client: DEXCOM, INC. · Firm: DEXCOM, INC.

Open original LDA filing ↗

Cited source text

CGM Coverage policies Issues related to Medicare coverage and payment for breakthrough medical devices H.R.1691, Ensuring Patient Access to Critical Breakthrough Products Act

H.R. 3723

Medical Device Electronic Labeling Act

Client: DEXCOM, INC. · Firm: DEXCOM, INC.

Open original LDA filing ↗

Cited source text

CGM Coverage policy Issues related to the sterilization of medical devices Issues related to medical device electronic labeling H.R.3723, Medical Device Electronic Labeling Act H.R.1328, Medical Device Nonvisual Accessibility Act Issues related to artificial intelligence and other machine learning advances in healthcare Issues related to advances in diabetes technology

H.R. 3723

Medical Device Electronic Labeling Act

Client: DEXCOM, INC. · Firm: DEXCOM, INC.

Open original LDA filing ↗

Cited source text

CGM Coverage policy Issues related to sterilization of medical devices Issues related to medical device electronic labeling H.R.3723, Medical Device Electronic Labeling Act H.R.1328, Medical Device Nonvisual Accessibility Act Issues related to artificial intelligence and other machine learning advances in healthcare Issues related to advances in diabetes technology

H.R. 3723

Medical Device Electronic Labeling Act

Client: DEXCOM, INC. · Firm: DEXCOM, INC.

Open original LDA filing ↗

Cited source text

CGM Coverage policy Issues related to sterilization of medical devices Issues related to medical device electronic labeling H.R.3723, Medical Device Electronic Labeling Act H.R.1328, Medical Device Nonvisual Accessibility Act Issues related to artificial intelligence and other machine learning advances in healthcare Issues related to advances in diabetes technology

H.R. 3723

Medical Device Electronic Labeling Act

Client: DEXCOM, INC. · Firm: DEXCOM, INC.

Open original LDA filing ↗

Cited source text

CGM Coverage policy Issues related to sterilization of medical devices Issues related to medical device electronic labeling H.R.3723, Medical Device Electronic Labeling Act H.R.1328, Medical Device Nonvisual Accessibility Act Issues related to artificial intelligence and other machine learning advances in healthcare Issues related to advances in diabetes technology

Show 7 more original filings

DEXCOM, INC. via DEXCOM, INC.

2025 · third_quarter · Q3

Firm income: —Client expense: $370,000Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

HCR

Health Issues

MMM

Medicare/Medicaid

CGM Coverage policies Issues related to breakthrough technology

TRD

Trade (domestic/foreign)

Issues related to global supply chains Issues related to the Administration's Executive Orders

Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE

DEXCOM, INC. via DEXCOM, INC.

2025 · second_quarter · Q2

Firm income: —Client expense: $290,000Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

HCR

Health Issues

MMM

Medicare/Medicaid

CGM Coverage policies Issues related to breakthrough technology

TRD

Trade (domestic/foreign)

Issues related to global supply chains Issues related to the Administration's Executive Orders

Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE

DEXCOM, INC. via DEXCOM, INC.

2025 · first_quarter · Q1

Firm income: —Client expense: $270,000Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

HCR

Health Issues

MMM

Medicare/Medicaid

CGM Coverage policies Issues related to breakthrough technology

TRD

Trade (domestic/foreign)

Issues related to global supply chains Issues related to the Administrations Executive Orders

Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

DEXCOM, INC. via DEXCOM, INC.

2024 · fourth_quarter · Q4

Firm income: —Client expense: $260,000Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

TRD

Trade (domestic/foreign)

Issues related to global supply chains

MMM

Medicare/Medicaid

CGM Coverage policies Issues related to Medicare coverage and payment for breakthrough medical devices H.R.1691, Ensuring Patient Access to Critical Breakthrough Products Act

HCR

Health Issues

CGM Coverage policy Issues related to sterilization of medical devices Issues related to medical device electronic labeling H.R.3723, Medical Device Electronic Labeling Act H.R.1328, Medical Device Nonvisual Accessibility Act Issues related to artificial intelligence and other machine learning advances in healthcare Issues related to advances in diabetes technology

DEXCOM, INC. via DEXCOM, INC.

2024 · third_quarter · Q3

Firm income: —Client expense: $130,000Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

HCR

Health Issues

MMM

Medicare/Medicaid

CGM Coverage policies Issues related to Medicare coverage and payment for breakthrough medical devices H.R.1691, Ensuring Patient Access to Critical Breakthrough Products Act

TRD

Trade (domestic/foreign)

Issues related to global supply chains

DEXCOM, INC. via DEXCOM, INC.

2024 · second_quarter · 2A

Firm income: —Client expense: $170,000Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

MMM

Medicare/Medicaid

CGM Coverage policies Issues related to Medicare coverage and payment for breakthrough medical devices H.R.1691, Ensuring Patient Access to Critical Breakthrough Products Act

TRD

Trade (domestic/foreign)

Issues related to global supply chains

HCR

Health Issues

DEXCOM, INC. via DEXCOM, INC.

2024 · first_quarter · 1A

Firm income: —Client expense: $160,000Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

MMM

Medicare/Medicaid

CGM Coverage policies Issues related to Medicare coverage and payment for breakthrough medical devices H.R.1691, Ensuring Patient Access to Critical Breakthrough Products Act

TRD

Trade (domestic/foreign)

Issues related to global supply chains

HCR

Health Issues

CGM Coverage policy Issues related to the sterilization of medical devices Issues related to medical device electronic labeling H.R.3723, Medical Device Electronic Labeling Act H.R.1328, Medical Device Nonvisual Accessibility Act Issues related to artificial intelligence and other machine learning advances in healthcare Issues related to advances in diabetes technology